Stocktoria
Canopy Growth Corp CGC
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products · website · IPO 2010-06-04
Chart by TradingView
4/9
Piotroski F — financial health
—
Altman Z″ — distress risk
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $284.6M | $269.0M | $343.9M | $333.3M | $537.6M |
| Gross profit | $69.7M | $79.5M | $80.9M | -$63.5M | -$187.4M |
| Operating income | -$161.7M | -$117.1M | -$228.7M | -$2.6B | -$1.0B |
| Net income | -$262.9M | -$508.9M | -$693.7M | -$3.3B | -$310.0M |
| Operating cash flow | -$63.8M | -$165.8M | -$228.4M | -$394.4M | -$446.3M |
| Free cash flow | -$69.1M | -$176.6M | -$231.9M | -$403.5M | -$483.0M |
| Total assets | $1.1B | $917.7M | $1.3B | $2.4B | $5.6B |
| Total liabilities | $421.1M | $439.1M | $899.8M | $1.7B | $2.0B |
| Shareholders' equity | $697.6M | $478.6M | $400.4M | $760.0M | $3.6B |
| Ratios | |||||
| Gross margin | 24.5% | 29.6% | 23.5% | -19.1% | -34.9% |
| Operating margin | -56.8% | -43.5% | -66.5% | -789.3% | -189.5% |
| Net margin | -92.4% | -189.2% | -201.7% | -983.7% | -57.7% |
| FCF margin | -24.3% | -65.6% | -67.4% | -121.1% | -89.8% |
| Return on assets | -23.5% | -55.5% | -53.3% | -134.4% | -5.5% |
| Return on equity | -37.7% | -106.3% | -173.2% | -431.3% | -8.6% |
| Debt / equity | 0.33× | 0.63× | 1.23× | 0.99× | 0.42× |
| Current ratio | 3.34 | 2.86 | 1.11 | 1.34 | 8.10 |
| Revenue growth | 5.8% | -21.8% | 3.2% | -38.0% | -11.5% |
Why these scores methodology →
Piotroski F-score: 4/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: n/a
Not applicable (financials/insurer or missing inputs).
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001737927 · as of 2026-03-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.